These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 11818473)

  • 21. An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Davis TM
    Intern Med J; 2010 Apr; 40(4):286-92. PubMed ID: 19323700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why does diabetes mellitus increase the risk of cardiovascular disease?
    Shahab A
    Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relation of insulin resistance syndromes to risk of cardiovascular disease.
    Nesto RW
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S11-8. PubMed ID: 14668699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The type 2 tablet. Evidence based medication for type 2 diabetes.
    Phillips P; Braddon J
    Aust Fam Physician; 2003 Jun; 32(6):431-6. PubMed ID: 12833770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes and hypertension: a review.
    Sowers JR; Khoury S
    Prim Care; 1991 Sep; 18(3):509-24. PubMed ID: 1658839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome in the prevention of cardiovascular diseases and diabetes--still a matter of debate?
    Ma X; Zhu S
    Eur J Clin Nutr; 2013 May; 67(5):518-21. PubMed ID: 23403882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Framingham Study, diabetes mellitus and cardiovascular disease: turning back the clock.
    Kengne AP; Turnbull F; MacMahon S
    Prog Cardiovasc Dis; 2010; 53(1):45-51. PubMed ID: 20620425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of cardiovascular complications in type 2 diabetes mellitus.
    Meigs JB
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S358-61. PubMed ID: 14704869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nontraditional risk factors for cardiovascular disease in diabetes.
    Fonseca V; Desouza C; Asnani S; Jialal I
    Endocr Rev; 2004 Feb; 25(1):153-75. PubMed ID: 14769830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
    Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM
    Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
    Zarich SW
    Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid disorders in type 2 diabetes.
    Braun LT
    Nurs Clin North Am; 2001 Jun; 36(2):291-302, vii. PubMed ID: 11382564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
    McLaughlin T; Abbasi F; Lamendola C; Reaven G
    Arch Intern Med; 2007 Apr; 167(7):642-8. PubMed ID: 17420421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for diabetes, but not for cardiovascular disease, are associated with family history of Type 2 diabetes in subjects from central Mexico.
    Zamora-Ginez I; Pérez-Fuentes R; Baez-Duarte BG; Revilla-Monsalve C; Brambila E;
    Ann Hum Biol; 2012 Mar; 39(2):102-7. PubMed ID: 22324835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C and the risk of cardiovascular disease: an evolving epidemic?
    Aytaman A; McFarlane SI
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):439-42. PubMed ID: 16918263
    [No Abstract]   [Full Text] [Related]  

  • 36. Diabetes epidemiology as a tool to trigger diabetes research and care.
    Zimmet PZ
    Diabetologia; 1999 May; 42(5):499-518. PubMed ID: 10333041
    [No Abstract]   [Full Text] [Related]  

  • 37. C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones.
    Nesto R
    Diabet Med; 2004 Aug; 21(8):810-7. PubMed ID: 15270782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
    Hodge AM; Dowse GK; Zimmet PZ
    Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Klinefelter syndrome, insulin resistance, metabolic syndrome, and diabetes: review of literature and clinical perspectives.
    Salzano A; D'Assante R; Heaney LM; Monaco F; Rengo G; Valente P; Pasquali D; Bossone E; Gianfrilli D; Lenzi A; Cittadini A; Marra AM; Napoli R
    Endocrine; 2018 Aug; 61(2):194-203. PubMed ID: 29572708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD].
    ; Rydén L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes HP; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Sousa Uva M; Taskinen MR; Tendera M; Tuomilehto J; Valensi P; Zamorano JL;
    Kardiol Pol; 2013; 71 Suppl 11():S319-94. PubMed ID: 24297732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.